share_log

星股早报 | 凯德置地投资发行3.5亿新元优先票据;新加坡开发商7月销售额飙升236%,大众市场领涨

Morning news of Xinggu: Keppel Land invests in and issues 0.35 billion new yuan preferred bills; Singapore developers' sales in July surged by 236%, leading the mass market.

Futu News ·  Aug 16 10:06

Good morning, everyone! Here is the market overview of Singapore this morning:

  • Singapore's stock market opened high on Friday, with the Straits Times Index up 1.18%.

  • Singapore developers' sales surged 236% in July, leading the mass market.

  • Focus stocks: Keppel Investment, Cordlife and Uob Kay Hian Holdings.

  • Latest share repurchase transactions.

Market performance.

Singapore's stock market opened higher on Friday. As of 10:00 AM, The weather is good today The weather is good today. it rose 1.17% to 3354.36 points, with 112 shares rising and 46 falling.

Market news.

Singapore developers' sales surged by 236% in July, with strong performance in the mass market.

According to data from the Urban Redevelopment Authority (URA) of Singapore, private residential sales in Singapore rose by 236.4% month-on-month in July, with a total of 571 units sold. PropNex emphasized that this is the second highest monthly sales volume since 2024, which is attributed to the launch of new projects in the mass market sector. Outside the Central Region (OCR) led the way with 444 new homes sold, a significant increase from 132 in June. Sales in other central regions (RCR) also increased, reaching 106 units, a 49% increase from the previous month. However, sales in the Core Central Region (CCR) declined, with only 21 units sold, the lowest level since December 2018. Sales of Executive Condominiums (EC) fell by 26%, with 37 new homes sold, as inventory of unsold ECs remained scarce.

Focus stocks

$CapitaLandInvest (9CI.SG)$$Cordlife Group (P8A.SG)$: Cordlife Group reported a loss of SGD 12.4 million in the first half of the year, in sharp contrast to a profit of SGD 2.2 million in the same period last year, with revenue plummeting 67.5% to SGD 9.2 million. The decline is mainly due to the suspension of its Singapore business due to storage errors, with the Ministry of Health issuing a six-month suspension order in November 2023, followed by a three-month suspension. To make matters worse, the Cord Blood and Tissue Banking Accreditation (AABB) has revoked Cordlife's cord blood activity certification. The company is taking corrective measures, including setting up a supervisory committee and a technical advisory committee, and reallocating funds for strategic investments to address current challenges. Cordlife's stock price fell before the announcement, indicating investor concern about the company's recent operational issues and loss of certification.

$Cordlife (P8A.SG)$

$UOB Kay Hian (U10.SG)$UOB Kay Hian's report stated that due to the strong US stock market and increased trading volume, profit increased 64.3% to SGD 0.1139 billion and revenue increased 10.2% to SGD 0.3171 billion in the first half of the year. Despite a decrease in interest income, commission and trading income grew 18.8% to SGD 0.166 billion, and operational costs also decreased.

Share buyback

Source: The Business Times, SGinvestors.io, Business Review

Editor/Feynman

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment